Advocacy for the inclusion of Midazolam Autoinjectors and Atropine Autoinjectors in the Strategic National Stockpile, as well as for procurement by of the same autoinjectors by the Department of Defense. Advocated for procurement in the upcoming FY26 Continuing Resolution and the FY26 Appropriations process.
2025 · 3rd Quarter (July 1 - Sep 30)
RAFA LABORATORIES, LTD
Filed by MILNE, WIENER & SHOFE GLOBAL STRATEGIES (FKA M & W GOVERNMENT AFFAIRS, LLC).
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 24, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Client
- RAFA LABORATORIES, LTD
- Filing UUID
- ecfaca19-9601-47e0-8476-956451c18ffc
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Advocacy for the inclusion of Midazolam Autoinjectors and Atropine Autoinjectors in the Strategic National Stockpile
Advocating for the procurement of midazolam autoinjectors and atropine autoinjectors for the Department of Defense
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.